Walgreens and CDC to Evaluate HIV Care Model at More Than 700 HIV-Specialized Pharmacies
DEERFIELD, Ill., December 16, 2013 - In support of the more than 1.1 million people living with HIV in the U.S., Walgreens (NYSE: WAG) (Nasdaq: WAG) is collaborating with the Centers for Disease Control and Prevention (CDC) to develop and evaluate a model of HIV patient-centered care through a national project aimed at advancing clinical integration and medication therapy management. The program is another way Walgreens is extending its commitment to improve HIV prevention and treatment outcomes.
Walgreens is leveraging the expertise of its more than 700 HIV-specialized pharmacies and specially trained pharmacists to lead medication care plans and provide data evaluation and outcomes reporting for 1,000 HIV positive project participants. Walgreens pharmacists, who routinely provide pharmacy care and treatment for people living with HIV, will meet one-on-one with project participants to create care plans that focus on medication adherence and address other needs including health education for added chronic conditions.
“Our approach to improving HIV prevention and treatment is individualized care focused on the holistic needs of patients,” said Glen Pietrandoni, senior manager, virology, Walgreens. “Beyond dispensing medication, our pharmacists are trained to provide testing, confidential wellness consultations, coordinate care and benefits with physicians and insurance providers, and to help patients access financial support programs to reduce medication costs. However, medication adherence remains our primary objective because we know that taking the right medication at the right time is key to improving health outcomes.”
A Walgreens study of more than 15,000 HIV patients showed that those who received care through one of its HIV-specialized pharmacies, with expert-level trained pharmacists, were significantly more adherent to their medication (74 percent) than those receiving care through a traditional, non-specialized Walgreens pharmacy (69 percent).1 Adherent HIV patients are more likely to achieve improved health outcomes and suppressed viral loads, which make the virus less likely to be transmittable. 1 However, the CDC estimates only 25 percent of Americans with HIV have the virus under control.2
Walgreens collaboration with the CDC supports the goals the National HIV/AIDS Strategy and underscores its commitment to support communities affected by HIV/AIDS. Its HIV-specialized pharmacies continue to cooperate with local health departments and AIDS service organizations to support HIV testing and community events, and work with local health care providers, government leaders and religious organizations to continually assess and meet the needs of individuals in select communities throughout the U.S.
As the nation's largest drugstore chain with fiscal 2013 sales of $72 billion, Walgreens (www.walgreens.com) vision is to be the first choice in health and daily living for everyone in America, and beyond. Each day, Walgreens provides more than 6 million customers the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice in communities across America. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail service, along with respiratory services. These services improve health outcomes and lower costs for payers including employers, managed care organizations, health systems, pharmacy benefit managers and the public sector. The company operates 8,197 drugstores in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Take Care Health Systems is a Walgreens subsidiary that is the largest and most comprehensive manager of worksite health and wellness centers, provider practices, and in-store convenient care clinics, with more than 750 locations throughout the country.
1. Murphy P, Cocohoba J, Tang M, et al. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS PatientCare and STDs, Volume 26, Number 9, 2012.
2. Hall HI, Frazier EL, Rhodes P, et al. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med. 2013 Jul 22;173(14):1337-44. doi: 10.1001/jamainternmed.2013.6841.